Suppr超能文献

一种来源于盲鳗肠道肽的活性域 HF-18,可有效抑制耐药菌在体外/体内的生长。

An active domain HF-18 derived from hagfish intestinal peptide effectively inhibited drug-resistant bacteria in vitro/vivo.

机构信息

School of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu 211198, PR China.

School of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu 211198, PR China.

出版信息

Biochem Pharmacol. 2020 Feb;172:113746. doi: 10.1016/j.bcp.2019.113746. Epub 2019 Dec 6.

Abstract

Antibiotic resistance is spreading faster than the development of new antibiotics into clinical practice. Currently, the design of antimicrobial peptides (AMPs), potential new antibacterial agents with rare antimicrobial resistance, is the available strategy to enhance the antimicrobial activity and lower the toxicity of AMPs. In this study, a peptide derived from hagfish intestinal peptide was designed and termed as HF-18 (GFFKKAWRKVKKAFRRVL). After antimicrobial/bactericidal test in vitro, we found that HF-18 exhibited a potent antimicrobial activity with MIC of only 4 μg/ml against drug-resistant Staphylococcus aureus (S. aureus). Meanwhile, it eliminated the test bacteria within 1 h, suggesting its rapid bactericidal effect. Importantly, this peptide had no obvious hemolytic activity and cytotoxicity to mammalian cells. Furthermore, its notable antimicrobial effects in vivo was confirmed again in S. aureus induced mouse bacteremia and skin wound infection, reflecting as the decrease in bacterial counts in mouse lung or skin (up to 1.9 or 3.5 log CFU respectively), and including the inhibitory activity on inflammatory cytokines secretion. The possible mechanisms underlying HF-18 against drug-resistant S. aureus may attribute that HF-18 neutralized the negative charge in S. aureus surface and then disrupted the integrity of cell membranes to enhance the permeation of bacterial membrane, showing as the increased uptake of NPN and PI and the obvious morphology changes of S. aureus. In addition, this peptide bound to bacterial genomic DNA to suppress the expression of Panton-Valentine leukocidin (pvl) and nuclease (nuc) genes, which play major roles in S. aureus virulence. The properties of HF-18 suggest a path towards developing antibacterial agents that has stronger antibacterial activity and greater security for clinical treatment of infection induced by S. aureus, especially drug-resistant S. aureus.

摘要

抗生素耐药性的传播速度快于新抗生素进入临床实践的速度。目前,设计抗菌肽(AMPs)是一种可行的策略,这些抗菌肽是具有潜在抗菌作用的新型抗菌药物,其抗菌活性增强,毒性降低。在这项研究中,设计了一种源自盲鳗肠道肽的肽,并将其命名为 HF-18(GFFKKAWRKVKKAFRRVL)。经过体外抗菌/杀菌试验,我们发现 HF-18 对耐药金黄色葡萄球菌(S. aureus)具有很强的抗菌活性,MIC 仅为 4μg/ml。同时,它在 1 小时内消除了测试细菌,表明其具有快速杀菌作用。重要的是,这种肽对哺乳动物细胞没有明显的溶血活性和细胞毒性。此外,它在金黄色葡萄球菌诱导的小鼠菌血症和皮肤伤口感染中的显著抗菌作用再次得到证实,反映为小鼠肺部或皮肤中的细菌计数减少(分别高达 1.9 或 3.5 对数 CFU),包括对炎症细胞因子分泌的抑制作用。HF-18 对耐药金黄色葡萄球菌的可能作用机制可能归因于 HF-18 中和了金黄色葡萄球菌表面的负电荷,然后破坏了细胞膜的完整性,增强了细菌膜的通透性,表现为 NPN 和 PI 的摄取增加以及金黄色葡萄球菌的形态明显变化。此外,这种肽与细菌基因组 DNA 结合,抑制了 Panton-Valentine 白细胞毒素(pvl)和核酸酶(nuc)基因的表达,这些基因在金黄色葡萄球菌的毒力中起主要作用。HF-18 的特性表明,开发具有更强抗菌活性和更大临床安全性的抗菌药物,用于治疗金黄色葡萄球菌感染,特别是耐药金黄色葡萄球菌感染,是一条可行的途径。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验